- Featured Product
- KD/KO Validated
RFX6 Polyklonaler Antikörper
RFX6 Polyklonal Antikörper für WB, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, Indirect ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 22551-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
22551-1-PBS bindet in WB, Indirect ELISA RFX6 und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Polyklonal |
| Typ | Antikörper |
| Immunogen | RFX6 fusion protein Ag18235 |
| Vollständiger Name | regulatory factor X, 6 |
| Berechnetes Molekulargewicht | 928 aa, 102 kDa |
| Beobachtetes Molekulargewicht | 102 kDa |
| GenBank-Zugangsnummer | BC039248 |
| Gene symbol | RFX6 |
| Gene ID (NCBI) | 222546 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Antigen-Affinitätsreinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
The RFX proteins represent an essential class II transcription factor family that share several conserved regions, including a centrally located DNA-binding domain (DBD) and a C-terminal D region that facilitates dimerization. RFX6, also known as RFXDC1, is a 928 amino acid nuclear protein that, via interactions with other RFX proteins, can bind DNA and is thought to activate the transcription of target genes. RFX6 is specifically expressed in pancreas, small intestine and colon. Mutations in the gene encoding RFX6 is the cause of the Mitchell-Riley syndrome (MIRIS), which is characterized by neonatal diabetes, duodenal and jejunal atresia, a hypoplastic or annular pancreas and absent gallbladder.



